|
全国免费电话：400-668-6834 -- 仅限中国地区 -- |
在线订购：QQ: 4006686834 电话订购：021-68591985 邮件订购：info@selleck.cn 我们也提供销售人员上门服务 |
技术支持电话：400-168-6834 我们将于一个工作日与您联系 |
Tafasitamab (Anti-CD19)
目录号：A2563 批次号: A256303
Tafasitamab (Anti-CD19)是一种 Fc 修饰的人源化单克隆抗体，可与人 B 细胞表面抗原 CD19 结合。它与同种异体 NK 细胞疗法联合用于治疗 B 细胞非霍奇金淋巴瘤。分子量：145.5 KD。
抗体信息
| CAS号 | 1422527-84-1 |
|---|---|
| 配制 | 100 mM Pro-Ac, 20mM Arg, pH5.0 |
| 推荐同型对照 | Human IgG1 |
| 来源 | CHO |
| 储存条件 (自收到货起) |
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
| 除菌 | 0.2 μM filtered |
| 纯度 | 99% |
| 蛋白浓度 | 10.3mg/ml |
| 内毒素 | ＜1EU/mg |
Tafasitamab (Anti-CD19)在文献中得到引用
| Cytokine-induced memory-like NK cells combined with Tafasitamab demonstrate efficacy against B-cell acute lymphoblastic leukemia [ Immunotherapy Advances, July 16, 2025, ltaf025] | PubMed: 40672109 |
| Anti-CD19 antibody cotreatment enhances serial killing activity of anti-CD19 CAR-T/-NK cells and reduces trogocytosis [ Blood, February 27, 2025, 956-969] | PubMed: 39652779 |
| Anti-CD19 antibody cotreatment enhances serial killing activity of anti-CD19 CAR-T/-NK cells and reduces trogocytosis [ Blood, December 9, 2024, 956-969] | PubMed: 39652779 |
| Cytokine-induced memory-like NK cells combined with Tafasitamab demonstrate efficacy against B-cell acute lymphoblastic leukemia [ Immunother Adv, 2025, 5(1):ltaf025] | PubMed: 40672109 |
禁止用于人体及治疗！